ID

40243

Beschreibung

Study ID: 110635 Clinical Study ID: 110635 Study Title: A double-blind, randomized, placebo controlled, parallel group, multi-center, phase III trial of ofatumumab investigating clinical efficacy in adult patients with active rheumatoid arthritis who had an inadequate response to methotrexate therapy (FINAL ANALYSIS: follow-up period and cumulative safety data across the whole study) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00611455 Sponsor: GlaxoSmithKline Phase: Phase 3 Study Recruitment Status: Completed Generic Name: ofatumumab, Placebo Study Indication: Arthritis, Rheumatoid

Stichworte

  1. 24.03.20 24.03.20 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

24. März 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Efficacy of ofatumumab in adult patients with active rheumatoid arthritis with inadequate response to methotrexate NCT00611455

End of Double Blind - Administrative; Subject Continuation; Phase Conclusion

Administrative
Beschreibung

Administrative

Alias
UMLS CUI-1
C1320722
Date of Visit/ Assessment
Beschreibung

Date of Visit/ Assessment

Datentyp

date

Alias
UMLS CUI [1,1]
C1320303
UMLS CUI [1,2]
C2985720
Subject Continuation
Beschreibung

Subject Continuation

Alias
UMLS CUI-1
C0805733
Is the subject continuing in the study?
Beschreibung

If the subject is an early withdrawal, tick No for subject continuation If yes, complete the Phase conclusion section and proceed with the Open-label Period If No, complete the Phase conclusion section and proceed with the Follow-up Period

Datentyp

boolean

Alias
UMLS CUI [1]
C0805733
Phase Conclusion
Beschreibung

Phase Conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0205390
Did the subject fail to complete this phase of the study?
Beschreibung

If yes, complete date and primary reason for withdrawal

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0805732
UMLS CUI [1,2]
C0231175
UMLS CUI [2,1]
C0205390
UMLS CUI [2,2]
C2603343
Date subject failed to complete
Beschreibung

Date subject failed to complete

Datentyp

date

Alias
UMLS CUI [1,1]
C0805732
UMLS CUI [1,2]
C0231175
UMLS CUI [2,1]
C0205390
UMLS CUI [2,2]
C2603343
UMLS CUI [3]
C0011008
Primary reason for withdrawal
Beschreibung

Primary reason for withdrawal

Datentyp

integer

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0392360
Specify Investigator discretion
Beschreibung

Specify Investigator discretion

Datentyp

text

Alias
UMLS CUI [1,1]
C2348235
UMLS CUI [1,2]
C0008961
UMLS CUI [1,3]
C0022423
Specify withdrew consent
Beschreibung

Specify withdrew consent

Datentyp

text

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C2348235

Ähnliche Modelle

End of Double Blind - Administrative; Subject Continuation; Phase Conclusion

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Administrative
C1320722 (UMLS CUI-1)
Date of Visit/ Assessment
Item
Date of Visit/ Assessment
date
C1320303 (UMLS CUI [1,1])
C2985720 (UMLS CUI [1,2])
Item Group
Subject Continuation
C0805733 (UMLS CUI-1)
Is the subject continuing in the study?
Item
Is the subject continuing in the study?
boolean
C0805733 (UMLS CUI [1])
Item Group
Phase Conclusion
C1707478 (UMLS CUI-1)
C0205390 (UMLS CUI-2)
Did the subject fail to complete this phase of the study?
Item
Did the subject fail to complete this phase of the study?
boolean
C0805732 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C0205390 (UMLS CUI [2,1])
C2603343 (UMLS CUI [2,2])
Date subject failed to complete
Item
Date subject failed to complete
date
C0805732 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C0205390 (UMLS CUI [2,1])
C2603343 (UMLS CUI [2,2])
C0011008 (UMLS CUI [3])
Item
Primary reason for withdrawal
integer
C0422727 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Code List
Primary reason for withdrawal
CL Item
Adverse event (1)
CL Item
Lack of efficacy (2)
CL Item
Protocol deviation (3)
CL Item
Subject reached protocol-defined stopping criteria (4)
CL Item
Study closed/terminated (5)
CL Item
Lost to follow-up (6)
CL Item
Investigator discretion, specify (7)
CL Item
Withdrew consent, specify (8)
CL Item
Prohibited medication use  (029)
Specify Investigator discretion
Item
Specify Investigator discretion
text
C2348235 (UMLS CUI [1,1])
C0008961 (UMLS CUI [1,2])
C0022423 (UMLS CUI [1,3])
Specify withdrew consent
Item
Specify withdrew consent
text
C1707492 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video